GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Return on Assets (ROA) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| ROA(%) | 25.40 | 25.15 | 17.87 | 15.76 | 10.11 |
What is the latest Return on Assets (ROA) ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Return on Assets (ROA) |
|---|---|
| Mar2026 | 25.40 |
| Mar2025 | 25.15 |
| Mar2024 | 17.87 |
| Mar2023 | 15.76 |
| Mar2022 | 10.11 |
How is Return on Assets (ROA) of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Return on Assets (ROA) | % Change | |
|---|---|---|---|
| Mar2026 | 25.4 | 0.99 | |
| Mar2025 | 25.15 | 40.74 | |
| Mar2024 | 17.87 | 13.39 | |
| Mar2023 | 15.76 | 55.89 | |
| Mar2022 | 10.11 | - | |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Assets (ROA) ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹45,553.4 Cr | 3.4% | 7.3% | -0.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 3.4% |
7.3% |
-0.5% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses